Future of the Nephrostomy Devices Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Nephrostomy Devices Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the market size of nephrostomy devices. The market is expected to surge from $1.2 billion in 2024 to $1.3 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. Various factors contributed to this growth during the past period. Some of these include the increased occurrence of kidney stone disease, a rise in the number of aging individuals, improved reimbursement policies, expanded applications in urological processes, heightened awareness, a surge in kidney-related illnesses, and an upgraded healthcare infrastructure.

How Will the Nephrostomy Devices Market Size Evolve and Grow by 2029?
The market size for nephrostomy devices is predicted to experience robust growth in the upcoming years, estimated to reach $1.77 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. The anticipated growth during the projected period is attributed to factors like the increasing incidents of kidney diseases, growing elderly population, development of healthcare infrastructure in emerging economies, increased recognition and diagnosis of urological disorders, expanded investment in research and development, and heightened awareness concerning nephrostomy methodologies. Significant trends for the forecast period involve progression in minimally invasive surgery techniques, technological developments in medical apparatus, advancements in the field of medical imaging technologies, technological enhancements in the design of nephrostomy devices, and progress in catheter development.

View the full report here:
https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

What Drivers Are Propelling the Growth of Nephrostomy Devices Market Forward?
The nephrostomy device market is set to experience substantial growth due to an uptick in kidney transplants. Kidney transplants involve a surgical procedure that replaces a person's failing kidney with a healthy one from a donor. The escalating number of transplants is attributed to the increasing prevalence of chronic kidney disease and kidney failure, combined with progression in medical technology and transplant methods. Nephrostomy devices aid in kidney transplants by offering a temporary remedy to drain urine directly from the kidneys when complications such as urinary tract blockages arise. This aids in maintaining optimal kidney function and minimizes the risk of infection or damage to the donated kidney during the crucial post-transplant recovery stage. For instance, data from the Health Resources and Services Administration (HRSA), a federal agency within the U.S. Department of Health and Human Services (HHS), revealed that in 2022, the number of adult candidates added to the kidney waiting list peaked at 44,187, exceeding the previous high of 42,932 in 2019 pre-pandemic. Also, the total number of adult candidates listed for a kidney transplant (including those registered at multiple centers) showed a slight increase to 140,165, up from 139,011 in 2021. Given these conditions, the increased incidence of kidney transplants is propelling the growth of the nephrostomy device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16493&type=smp

What Are the Key Trends Driving Nephrostomy Devices Market Growth?
Renowned corporations in the nephrostomy devices industry are inventing unique products such as catheters with pressure injection capability to enhance the efficiency of procedures and patient experiences. The concept of pressure injection in a catheter refers to the application of regulated force to transfer fluids or drugs through a cathetically-installed body, typically within the renal framework in the case of nephrostomy procedures. For example, in June 2022, Teleflex Incorporated, a US-based creator of medical appliances, unveiled the Arrow Pressure Injectable Midline. With its unique yellow hubs and labels, the Arrow Pressure Injectable Midline simplifies the identification of catheters, thereby mitigating the possibility of infusion errors. It also maintains a steady French size, minimizing the potential for venous stagnation. The precise placement of this apparatus during procedures is assured by a simplified tray configuration and ergonomically designed trimmer. Furthermore, it is designed with additional safety features that allow for quick pressure injections of up to 5 mL/second through either channel, thus reducing diagnosis and treatment delays.

What Are the Key Segments in the Nephrostomy Devices Market?
The nephrostomy devices market covered in this report is segmented -

1) By Product Type: Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators, Other Products
2) By Application: Kidney Diseases, Urological Cancer And Benign Prostatic Hyperplasia (BPH), Other Applications
3) By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:
1) By Guidewires: Straight Guidewires, Hydrophilic Guidewires, Coated Guidewires
2) By Drainage Tubes: Single-Lumen Drainage Tubes, Double-Lumen Drainage Tubes, Multilumen Drainage Tubes
3) By Nephrostomy Catheters: Percutaneous Nephrostomy Catheters, Suprapubic Nephrostomy Catheters
4) By Sheath Dilators: Standard Sheath Dilators, Hydrophilic Sheath Dilators
5) By Other Products: Nephrostomy Bags, Catheter Fixation Devices, Nephrostomy Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16493&type=smp

Who Are the Key Players Shaping the Nephrostomy Devices Market's Competitive Landscape?
Major companies operating in the nephrostomy devices market are Becton, Dickinson and Company, Stryker Healthcare, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Coloplast Corp., B. Braun Medical Inc., Cook Medical, Teleflex Incorporated, Merit Medical Systems, AngioDynamics, Argon Medical Devices, Well Lead Medical Co. Ltd., Amecath, Medi-Globe GmbH, Envaste Limited, Troge Medical GmbH, Rocamed, Suru International Pvt.Ltd., UroMed, Electramed Ltd., Urovision-Urotech, Blueneem Medical Devices Pvt Ltd., Manfred Sauer UK, Surgimedik Healthcare India Pvt Ltd

What Geographic Markets Are Powering Growth in the Nephrostomy Devices Market?
North America was the largest region in the nephrostomy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nephrostomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16493

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.